Kurachi T, Morita I, Murota S
Second Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Graduate School, Tokyo Medical and Dental, University, Japan.
Biochim Biophys Acta. 1993 Sep 13;1178(3):259-66. doi: 10.1016/0167-4889(93)90202-z.
We report here that leukocyte function-associated antigen-1 (LFA-1) and intercellular adhesion molecule-1 (ICAM-1) are involved in osteoclast development. Osteoclast development was observed on co-culture of mouse spleen cells and mouse bone marrow derived clonal stromal cells, TMS-14, in the presence of 1 alpha, 25-dihydroxyvitamin D-3 (1 alpha, 25-(OH)2D3) for 8 days, and quantified with respect to tartrate-resistant acid phosphatase (TRACP) activity. When either one of the monoclonal antibodies (MAbs) to mouse LFA-1 and mouse ICAM-1 was added to the co-culture system, the TRACP activity was significantly inhibited. The experiment in which one-day treatment with each of these MAbs was performed during the 8 days of cultivation showed that the inhibitory effects of both MAbs on the TRACP activity at 8 days were observed from an early stage of the culture, but were more notable at a later stage (days 4-6). As the expression of ICAM-1 was observed on both spleen cells and TMS-14, we next examined whether the interaction between stromal cells and osteoclast progenitors or among osteoclast progenitors was more important for osteoclast development. To determine this, rat spleen cells and a MAb to rat ICAM-1 were used instead of those of mouse. When MAb to rat ICAM-1 or mouse ICAM-1 was added to the co-culture system of rat spleen cells and TMS-14, the inhibitory effect of the MAb to rat ICAM-1 was mainly observed at a later stage of the culture period and that of anti-mouse ICAM-1 antibody was only observed at an earlier stage. These results indicate that adhesion molecules LFA-1 and ICAM-1 may play a role in osteoclast development via interaction between stromal cells and osteoclast progenitors as well as among osteoclast progenitors.
我们在此报告,白细胞功能相关抗原-1(LFA-1)和细胞间黏附分子-1(ICAM-1)参与破骨细胞的发育。在1α,25-二羟基维生素D-3(1α,25-(OH)2D3)存在的情况下,将小鼠脾细胞与小鼠骨髓来源的克隆基质细胞TMS-14共培养8天,观察到破骨细胞的发育,并通过抗酒石酸酸性磷酸酶(TRACP)活性进行定量。当将抗小鼠LFA-1和抗小鼠ICAM-1的单克隆抗体(MAb)之一添加到共培养系统中时,TRACP活性受到显著抑制。在培养的8天期间对这些MAb进行为期一天的处理的实验表明,两种MAb对第8天TRACP活性的抑制作用从培养早期就已观察到,但在后期(第4 - 6天)更为显著。由于在脾细胞和TMS-14上均观察到ICAM-1的表达,接下来我们研究基质细胞与破骨细胞祖细胞之间或破骨细胞祖细胞之间的相互作用对破骨细胞发育是否更为重要。为了确定这一点,使用大鼠脾细胞和抗大鼠ICAM-1的MAb代替小鼠的。当将抗大鼠ICAM-1或抗小鼠ICAM-1的MAb添加到大鼠脾细胞和TMS-14的共培养系统中时,抗大鼠ICAM-1的MAb的抑制作用主要在培养后期观察到,而抗小鼠ICAM-1抗体的抑制作用仅在早期观察到。这些结果表明,黏附分子LFA-1和ICAM-1可能通过基质细胞与破骨细胞祖细胞之间以及破骨细胞祖细胞之间的相互作用在破骨细胞发育中发挥作用。